GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nanosphere Inc (NAS:NSPH) » Definitions » Cash And Cash Equivalents

Nanosphere (Nanosphere) Cash And Cash Equivalents : $13.40 Mil (As of Mar. 2016)


View and export this data going back to 2007. Start your Free Trial

What is Nanosphere Cash And Cash Equivalents?

Nanosphere's quarterly cash and cash equivalents increased from Sep. 2015 ($12.34 Mil) to Dec. 2015 ($15.11 Mil) but then stayed the same from Dec. 2015 ($15.11 Mil) to Mar. 2016 ($13.40 Mil).

Nanosphere's annual cash and cash equivalents declined from Dec. 2013 ($41.47 Mil) to Dec. 2014 ($21.05 Mil) and declined from Dec. 2014 ($21.05 Mil) to Dec. 2015 ($15.11 Mil).


Nanosphere Cash And Cash Equivalents Historical Data

The historical data trend for Nanosphere's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere Cash And Cash Equivalents Chart

Nanosphere Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.27 33.14 41.47 21.05 15.11

Nanosphere Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.22 20.86 12.34 15.11 13.40

Nanosphere Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Nanosphere  (NAS:NSPH) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Nanosphere Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Nanosphere's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosphere (Nanosphere) Business Description

Traded in Other Exchanges
N/A
Address
Nanosphere, Inc., was incorporated in 1999 in Delaware. The Company develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables sensitive genomic and protein testing on a single platform. The Verigene System includes a bench-top molecular diagnostics workstation that is an advanced platform for genomic and protein testing. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing. The Verigene System provides lower cost for laboratories already performing molecular diagnostic testing and enables smaller laboratories and hospitals without advanced diagnostic capabilities to perform genetic testing.
Executives
Michael James Ward director 440 W. ONTARIO ST., CHICAGO IL 60654
Lorin Randall director C/O ACORDA THERAPEUTICS, INC., 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
R. Erik Holmlin director 4088 COMMERCIAL AVE., NORTHBROOK IL 60062
Gene S Cartwright director 4088 COMMERCIAL AVE, NORTHBROOK IL 60062
Mmcap International Inc. Spc 10 percent owner C/O MOURANT GOVERNANCE SVCS (CAYMAN) LTD, 94 SOLARIS AVE., CAMANA BAY, PO BOX 1348, GRAND CAYMAN E9 KY1-1108
Ann Wallin officer: Interim CFO 4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062
Bruin Andre De director
Sheli Z Rosenberg director C/O EQUITY GROUP INVESTMENTS, L.L.C., TWO NORTH RIVERSIDE PLAZA, SUITE 600, CHICAGO IL 60606
Chad A. Mirkin director 4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062
Brookside Capital Management Llc 10 percent owner C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Brookside Capital Partners Fund Lp 10 percent owner C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Brookside Capital Investors L P 10 percent owner C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Fund 2005, L.p. 10 percent owner C/O BAIN CAPITAL, LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Partners 2005, L.p. 10 percent owner C/O BAIN CAPITAL, LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Investors, Llc 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116

Nanosphere (Nanosphere) Headlines

From GuruFocus

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk 05-06-2010

New Optical Disks May Boost the Gold Nanoparticles Industry

By Alberto Abaterusso Alberto Abaterusso 03-27-2018

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk 11-05-2009